Rare Diseases
News
The Life Raft Group Offers Free Online Webcast Series on GIST
News
Experts call for international cooperation on human gene editing
As the International Summit on Human Gene Editing comes to a close, organizers call for cooperation to establish norms for acceptable and ethical...
News
The Caring for Carcinoid Foundation Is Now the Neuroendocrine Tumor Research Foundation
News
Survivors of childhood cancers at increased risk for autoimmune diseases
Key clinical point: Survivors of childhood cancers, especially leukemia, Hodgkin lymphoma, and renal tumors, had a significantly increased risk of...
Conference Coverage
ITC 2015: Review IDs features to aid thyroid lymphoma diagnosis
Rapidly enlarging thyroid masses with compressive symptoms may signal thyroid lymphoma, according to findings from a review of cases at the Mayo...
Conference Coverage
Surgical options for Graves orbitopathy can be vision saving
In the face of serious – even vision-threatening – complications, endocrinologists treating patients with Graves orbitopathy should understand...
Conference Coverage
Percutaneous ethanol effective for small papillary thyroid cancers
Key clinical point: Ultrasound-guided percutaneous ethanol ablation (UPEA) is an efficacious, cost-effective, and noninvasive definitive treatment...
Conference Coverage
ITC: SELECT trial: Lenvatinib effects similar regardless of site, number of metastases
Outcomes in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib did not differ based on metastatic site,...
Conference Coverage
Thyroglobulin can’t predict pazopanib response in differentiated thyroid cancer
Key clinical point: Falling thyroglobulin levels cannot predict early response to pazopanib in differentiated thyroid cancers. Major finding:...
Conference Coverage
Cabozantinib shows promise in refractory differentiated thyroid cancer
Most patients with differentiated thyroid cancer who had shown progression on previous courses of targeted chemotherapy either maintained stable...